Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Proxeed Plus is a multi-ingredient dietary supplement specifically formulated to support male reproductive health and optimize sperm quality. Developed by Alfasigma (formerly Alfa Wassermann), it contains a patented blend of metabolic agents, antioxidants, and essential nutrients, including L-carnitine, acetyl-L-carnitine, fructose, citric acid, vitamin B12, selenium, coenzyme Q10, vitamin C, zinc, and folic acid. These components work synergistically to enhance sperm energy metabolism, protect spermatozoa from oxidative stress-induced damage, and support the maturation and functional integrity of sperm cells. It is primarily indicated for men with subfertility issues, such as asthenozoospermia (low sperm motility), oligozoospermia (low sperm count), or poor sperm morphology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Proxeed Plus.